Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Anticounterfeit Carrot & Stick: Radio Frequency I.D., No Paper Pedigree

Executive Summary

FDA's anticounterfeiting strategy advocates radio frequency identification in lieu of paper pedigrees to secure the drug supply chain

You may also be interested in...



FDA’s Drug Pedigree Enforcement To Focus Initially On High-Risk Products

FDA will adopt a phased-in approach to enforcing drug pedigree requirements in the upcoming year

FDA’s Drug Pedigree Enforcement To Focus Initially On High-Risk Products

FDA will adopt a phased-in approach to enforcing drug pedigree requirements in the upcoming year

Drug Tracking Goes Back To Task Force; Wholesalers Call For Updated Law

FDA's next step in assessing when to impose pedigree requirements for tracking drug shipments is the issuance of a report in May by the agency's Counterfeit Drug Task Force

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS043381

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel